Quotient (QTNT) Reports Q3 Loss of $0.48
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Quotient Limited Reports Third Quarter Fiscal 2016 Financial Results
February 8, 2016 7:45 AM ESTConsiderable progress on development and commercial scale-up of MosaiQ, Quotients next-generation automation platform for transfusion diagnosticsMarketing of MosaiQ expected to start in the fourth quarter of 2016 in Europe with U.S. commercial launch anticipated in the first quarter of 2018, if licensed for saleProduct sales of $4.4 million in 3QFY16, exceeding guidanceIn January, announced MosaiQ platform will be expanded to include Nucleic Acid Testing (or NAT)Priced an underwritten public offering of 4.4 million ordinary shares expected to raise net proceeds of $36.9... More



